In January, after the DermaSensor became the first artificial intelligence (AI)-enabled device cleared by the US Food and Drug Administration (FDA) to evaluate lesions suggestive of skin cancer, the ...
DermaSensor announced newly published studies supporting the performance of its device for evaluating suspicious skin lesions ...
Please provide your email address to receive an email when new articles are posted on . The device is a handheld tool that uses spectroscopy and algorithms to test worrisome skin lesions for cancer.
Symmetrical—lesions appear to be distributed in a similar arrangement on differing sides of the body (Figure 3, see slideshow) Once the configuration and distribution has been determined, the next ...
Enspectra Health today announced the publication of pivotal clinical trial results in JAMA Dermatology, demonstrating that its handheld cross-modal imaging system enables physicians to accurately ...
“It could empower patients and primary care providers to monitor suspicious skin lesions and seek help sooner.” He says the ...
TALLAHASSEE, Fla.--(BUSINESS WIRE)--DermaSensor Inc., a health technology company equipping primary care physicians (PCPs) with a non-invasive device for evaluating suspicious skin lesions and a proud ...
An artificial intelligence (AI)–enabled handheld elastic scattering spectroscopy (ESS) device improved the sensitivity for skin cancer diagnosis and management by primary care physicians (PCPs), with ...
Recent vitiligo research has challenged long-held assumptions about skin cancer risk in patients with depigmented lesions. A ...
A small handheld device called a dermatoscope is effective at detecting cancer. Could an extra 72 seconds in a routine skin exam help detect skin cancer? This month a group of experts from the United ...
A 5-year-old boy is referred from an Army hospital in Panama in the mid-1980s to Brooke Army Medical Center for evaluation of an unrelated problem when his parent asked about a case of several ...
This is likely the first case report on primary cutaneous follicle center lymphoma associated with bone marrow mastocytosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback